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Iron and folic acid deficiency during pregnancy are risk factors for anaemia, preterm 
delivery and low birth weight, and may contribute to poor neonatal health and 
increased maternal mortality. This study aimed at assessing knowledge, attitudes and 
practices regarding the use of iron and folic acid supplements among pregnant and 
lactating women taking ant-retroviral drugs in Dar es Salaam. A cross sectional survey 
involved 294 pregnant and lactating women in Temeke, Mwananyamala and Amana 
referral Hospitals in Dar es Salaam between May and July 2018. Data was analyzed 
using IBM SPSS. The findings revealed that, most of the study subjects were aware of 
both the benefits of iron and folic acid supplements and the consequences of iron and 
folic acid in case of any deficiency. Attitude towards use of iron and folic acid 
supplements among study subjects was also good. Closer to two thirds (60.2%) of the 
subjects perceived that one is likely to have some micronutrient deficiency when not 
taking iron and folic acid supplements.  Practice on the use of iron and folic acid 
supplements among study subjects was not satisfactory as only a small portion of the 
study subjects took these supplementation during pregnant and lactation. The findings 
revealed that the level of knowledge regarding iron and folic acid supplements use 
among pregnant and lactating women living with HIV is good. Attitudes towards use 
of iron and supplements were also good. But the use of iron and folic acid 
supplements in the study group is low. Community awareness campaigns on the use 
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1.1  Background   
Deficiency of iron and folic acid in pregnancy and lactating women is a worldwide 
public health problem affecting both developing and developed countries with 
significant impact on the health of mothers and foetus (Erharbor, 2013). Anaemia is an 
indicator of nutritional deficiencies that significantly contribute to birth defects, 
preterm labour and low birth weight. Anaemia caused by deficiency of iron and folic 
acid is a leading cause of maternal morbidity and mortality, prenatal and perinatal 
infant loss. In addition, these deficiencies may lead to physical and cognitive losses 
thus stall social and economic development in developing countries.  
 
In sub-Saharan African countries the magnitude of anaemia in pregnancy is quite 
alarming, and its prevalence is widely associated with low income, older maternal age, 
poor nutrition, iron, folic acid and other micronutrients deficiencies. Other factors are 
parasitic infestations, chronic infections, HIV, illiteracy, and short pregnancy intervals 
(Okeke, 2011). According to the WHO classification, any prevalence level of anaemia 
that exceeds 40% in any population group is an indicator of a severe public health 
problem, for which Tanzania qualifies. 
 
Pregnant women are advised to obtain needed nutrients from a balanced diet (Fawz et 
al 2000). Being HIV positive and pregnant or lactating cause additional demand on the 
body’s nutritional needs of the infected individuals as compared to non-infected 





status, women living with HIV should use iron and folic acid supplements. A prenatal 
iron and folic acid supplementation is likely to be beneficial and an easy, cost effective 
means to improve mother and neonatal health. Iron and folic acid supplements also 
prevent anaemia and maternal mortality and reduce abnormalities such as Neural Tube 
Defects (NTDs) and foetal deaths.  
 
Apart from iron and folic acid supplements, HIV-positive pregnant and lactating 
women should consume adequate amount of foods and fluids rich in energy, nutrients, 
protein, vitamins, minerals, dietary fiber and water. Studies associated with good 
nutrition from different countries have shown that dietary and micronutrients 
supplements are the key component of care and support for people living with HIV 
especially pregnant and lactating women (WHO, 2003). 
 
Acquired Immune Deficiency Syndrome (AIDS) is a disease caused by retrovirus the 
Human Immunodeficiency Virus (HIV). This disease affects and impairs the natural 
defense system of the body against diseases and infections. This epidemic disease is a 
worldwide disaster affecting society economically, politically, socially and culturally 
(NBS, 2011). The government of Tanzania has made substantial progress in 
HIV/AIDS prevention, care, treatment and impact mitigation. Progress has been made 
in resource mobilization, communication, advocacy and community participation. 
Prevalence of HIV/AIDS in Dar es Salaam, the major economic city and port of 
Tanzania is around 9% compared to a national prevalence that has stabilized at around 
6% (UNAIDS , 2015). Urban HIV prevalence is almost twice as high as rural HIV 





areas (UNAIDS, 2015). A study by THMIS, (2011) shows that, the prevalence of HIV 
among women who attend Ante-natal clinics in Dar es Salaam was 6.9%.  
 
1.2  Problem Statement and Justification 
Micronutrients deficiency especially Iron and folic acid in pregnancy and lactating, is 
a worldwide public health problem affecting both developing and developed countries 
with significant impact on the health of mothers and foetus (Erharbor, 2013). Anaemia 
is an indicator of nutritional deficiencies that significantly contribute to birth defects, 
preterm labour and low birth weight. Anaemia caused by deficiency of iron and folic 
acid is a leading cause of maternal morbidity and mortality, prenatal and perinatal 
infant loss. In addition, these deficiencies may lead to physical and cognitive losses 
thus stall social and economic development in developing countries.  
 
In sub-Saharan countries the magnitude of anaemia in pregnancy is quite alarming, 
and its prevalence is widely associated with low income, older maternal age, poor 
nutrition, iron, folic acid and other micronutrients deficiencies. Other factors are 
parasitic infestations, chronic infections, HIV, illiteracy, and short pregnancy intervals 
(Okeke, 2011).  
 
According to the WHO classification, any prevalence level of anaemia that exceeds 
40% in any population group is an indicator of a severe public health problem, for 
which Tanzania qualifies Various studies have been conducted in Tanzania on 
micronutrient supplements and anaemia. A study by Ogundipe et al, (2012) in 
northern Tanzania suggests low use of iron and folic acid supplementation for 





study by Urassa, (2002) revealed a very high prevalence of anaemia in pregnant 
women in Rufiji District.  Hinderaker et al (2001) found that anaemia in pregnancy 
was common in the area of high altitude in rural Tanzania. A study by Margwe (2015) 
confirms that preventing anaemia is a challenge as pregnant women had low 
knowledge and negative attitude towards control measures of anaemia in Mbulu 
district. High parity was found to be a risk factor for anaemia.   
 
Moodley et al (2014) suggested that, the increased prevalence of HIV may be 
explained by the fact that, this infection is associated with low serum folate, vitamin 
B12, and ferritin levels in pregnancy. Although there is much literature on anaemia in 
Tanzania, limited data is available, specifically for HIV pregnant and lactating women 
living in Dar es Salaam. Therefore, the current study will fill this gap by determining 
Knowledge, Attitudes and Practice regarding use of IFA supplements to among HIV 
pregnant and lactating women living in Dar es Salaam. 
 
1.3  Objectives of the Study  
1.3.1 General Objective 
To determine Knowledge, Attitudes and Practice regarding use of IFA supplements 
among pregnant and lactating women living with HIV in Dar es Salaam.  
 
1.3.2 Specific Objectives 
(i) To assess the level of knowledge on iron and folic acid supplements use among 
pregnant and lactating women living with HIV in Dar es Salaam.  
(ii) To identify the attitudes towards use of iron and folic acid supplements among 





(iii) To describe practices towards use of iron and folic acid supplements among 
pregnant and lactating women living with HIV in Dar es Salaam.  
 
(iv) To determine barriers to iron and folic acid supplements use among pregnant 
and lactating women living with HIV in Dar es Salaam.  
 
1.4  Research Questions 
(i) What is the level of knowledge on iron and folic acid supplements among HIV-
infected pregnant and lactating women attending PMTCT clinics in Dar es 
Salaam? 
(ii) What are the attitudes towards use of iron and folic acid supplements among 
HIV-infected pregnant and lactating women attending PMTCT clinics in Dar es 
Salaam? 
(iii) What are the practices towards use of iron and folic acid supplements among 
HIV-infected pregnant and lactating women attending PMTCT clinics in Dar es 
Salaam? 
(iv) What are the barriers to iron and folic acid supplements use among HIV-infected 
pregnant and lactating women attending PMTCT clinics in Dar es Salaam 
 
1.5  Significance of the Study 
The findings of the study will provide evidence-based information related to 
knowledge, attitudes and practices of pregnant and lactating women living with HIV 





government, through Ministry of Health Community Development Gender Elderly 
and Children, policy makers and other stakeholders in planning policies and programs 









































2.1  Knowledge of Women on the Importance of Iron and Folic Acid 
Supplementation  
Women of child-bearing age especially those living with HIV need iron and folic acid 
supplementations before pregnancy and in the first weeks of pregnancy to help prevent 
anaemia and NTDs. The need for folic acid supplementation is to reduce the 
occurrence of NTDs (Lumley et al, 2007). Data from previous studies have shown that 
pregnant women have low knowledge and understanding about the importance of folic 
acid for the foetal development and their practices often indicate this knowledge 
defect (Zeng et al, 2011). In United States, women of child-bearing age who were 
from poor socio-economic backgrounds knew little about the importance of the 
recommended daily intake of folic acid and only 25% of the total number of women 
surveyed reported consuming folic acid supplements daily (Sharp et al, 2011).  
 
2.2  Micronutrient Needs of HIV Pregnant and Lactating Women 
The HIV infected pregnant women need extra nutrients to meet their body 
requirements and to support foetal growth and future lactation. They also experience 
increased energy requirement due to HIV infection. Worse still, because of HIV 
infection they are likely to have deficiency of iron and folic acid. Pregnancy itself 
creates high demand of iron. These women may have opportunistic infections or other 
conditions that may increase food demand or interfere with food intake, digestion and 
absorption (TFNC, 2009). A breast feeding HIV positive woman needs to meet the 





for many nutrients and vitamins like vitamin A, B, C and E, and minerals like iodine, 
selenium, iron, folic acid and zinc are needed in higher amount during lactation than 
during pregnancy (Institute of medicine, 2000). Maternal micronutrients deficiencies 
especially iron and folic acid during lactation can cause a major reduction in the 
concentration of some of these nutrients in breast milk, with subsequent infant 
depletion (Allen et al, 2003).  
 
Based on categorising of the relation between maternal status or intake of each 
nutrient and its effect on the nutrient concentration in the breast milk, ‘priority’ 
nutrient for lactating women include thiamine, riboflavin, vitamin B6 and B12, 
vitamin A, and iodine (Popa et al, 2013). This is based on the fact that, low maternal 
intake of IFA supplements, reduce the amount of these nutrients in breast milk, and 
maternal supplementation can solve this problem.  
 
2.3 Benefits of Iron and Folic Acid Supplementation during Pregnancy and 
Lactation 
Micronutrients have a wide range of functions. More than one micronutrient may 
support a single function, e.g. antioxidant defense and a single micronutrient may act 
in more than one role, for example, iron is involved in both oxygen transport and 
immune function (Fawz et al, 2007). Evidence has shown that, the use of IFAS is 
associated with reduced risk of maternal iron deficiency anaemia and Neural Tube 
Defects (NTDs) in infants. Daily oral folic acid with 30 to 60 milligram and iron 400 
microgram (0.4 mg) is recommended for pregnant women to prevent maternal 
anaemia and NTDs (WHO, 2013). Interventions providing weekly iron and folic acid 





were successful in improving anaemia by using social marketing, community 
mobilization, and a government-industry partnership to promote the approach of iron 
supplements (Berger et al 2005).  
 
A study in Sweden revealed that, women who were not taking iron supplements had 
virtually no iron remaining in their bone marrow by late pregnancy, compared with 
35% of those who consumed 100 mg of iron daily from 16 week of gestation (Milman 
et al, 2005). In Tanzania, iron and folic acid supplements are provided during 
pregnancy through the health system; however, women often delay initiation of 
antenatal care and use of these supplements can be low (NBS, 2011). A study 
conducted by Ogundipe (2012), shows that iron and folic acid were low among 
childbearing women in Northern Tanzania. 
 
2.4  The Effects of HIV on Nutrition and Human Health 
Human immunodeficiency virus (HIV) is a virus that attacks cells that help the body 
fight infection, making a person more vulnerable to other infections and diseases. It is 
spread by contact with certain bodily fluids of a person with HIV, most commonly 
during unprotected sex (sex without a condom or HIV medicine to prevent or treat 
HIV), or through sharing injection drug equipment or mother-to-child transmissions.  
 
If HIV left untreated, can lead to AIDS disease. The HIV seeks and destroys immune 
system through CD4 cells, a type of T lymphocytes (T cells), which are critical to 
immune system. They are responsible for taking off diseases and most infections 
including viral infections (WHO, 2015). This virus targets the type of cells that will 





cells and produces more virus to infect more CD4 cells. Despite developments in 
medical treatment, nutrition remains a key component in managing this condition. The 
challenges the people living with HIV/AIDS face can be the result of the viral 
infection itself or from the effects of ART. Some of the side effects from ART that 
may affect how the body absorbs and utilizes nutrients include fatigue, nausea, and 
poor appetite (WHO, 2003).  
 
As well, the nutritional needs of people with HIV/AIDS are greater due to their 
immune system fighting off opportunistic infections that do not normally cause 
disease in people with healthy immune systems. Medication along with proper 
nutrition is a major component of maintaining good health and quality of life for 
people living with HIV/AIDS. The HIV epidemic does not affect the individual health 
only but affects households, communities and economic growth of countries. Many of 
the countries facing the burden of HIV also suffer from other infectious diseases, food 
insecurity and other serious problems and increase of orphans (WHO, 2015). 
 
The role of HIV infection on nutrition was identified early in the epidemic (Trujillo et 
al, 1992). Wasting is one of the most visible signs of malnutrition as person progress 
from HIV to AIDS. This virus found to affect nutritional status by increasing energy 
requirements, reducing food intake, and badly affecting nutrient absorption and 
metabolism, WHO (2003). Inability to meet nutritional needs may lead to decreased 
immunity and increased susceptibility to opportunistic infections, which can lead to 
anaemia and further malnutrition. Additionally, nutrient intake can improve 
antiretroviral absorption and tolerance (Maertens et al, 2011). Receiving nutritious 





Poor nutritional status in PLHIV speeds the disease progression, increases morbidity, 
and reduces life span (Hsu et al, 2005). For these reasons, nutritional support should 
be a very important part of a relevant response to HIV and AIDS (PEPFAR, 2006).  
 
The World Health Organization recommends ensuring micronutrient needs are met by 
increasing access to a diversified diet, fortified foods, and micronutrient supplements, 
particularly in areas where micronutrient deficiencies are endemic. However, these 
clinical issues remain common, despite improvements in the treatment and survival of 
PLHIV.  
 
2.5  Anti-retroviral Drugs use by Pregnant and Lactating Women  
 World Health Organization called for the elimination of new HIV infections among 
children by 2015 and keeping their mothers alive. The ART strategy for pregnant 
women is fully harmonized with the recommended first-line regimen for non-pregnant 
adults (once-daily tenofovir, lamivudine and efavirenz or emtracitabine). The 
prevention of mother to child transmission regimen will no longer be determined by 
the woman’s health status. Rather all HIV infected pregnant women, irrespective of 
CD4 -cell count or clinical stage, will initiate standard first-line ART to reduce the risk 
of HIV transmission to the child and to her uninfected partners. For good programme 
and operational reasons, particularly in generalized HIV epidemics, all pregnant and 











3.1  Study Design 
This was cross-sectional study based in a hospital setting. Both qualitative and 
quantitative techniques were employed in assessment of knowledge, attitudes and 
practices in the use of iron and folic acid supplements in women attending PMTCT 
clinics. 
 
3.2  Description of the Study Area 
The study was done in three Regional Referral Hospitals namely Amana, Temeke and 
Mwananyamala in Dar es Salaam. Dar es Salaam was purposely chosen because of its 
high prevalence of HIV infection. This city has a mix of different groups of people 
and is also the most populated city in Tanzania. The city has a population of about 
4,364,541 people (NBS, 2012). Dar es Salaam is the major commercial, administrative 
and industrial center of Tanzania. It is located between latitudes 6.36o and 7.0o to the 
south of Equator and longitudes 33.33 and 39.00 to the east of Greenwich. It is 
bordered by Indian Ocean on the East and Coast Region on the West.  
 
The total surface area of Dar es Salaam City is 1,800 km2, comprising of 1,393 km2 of 
land mass with eight offshore islands, which is about 0.19% of the entire Tanzania 
Mainland’s area. Economically, the city harbours high concentrations of trade and 
manufacturing business compared to other parts of Tanzania. Notable businesses 
include the Magogoni fish market at Kivukoni and clothing shops and agricultural 





shops. The city experiences tropical climatic conditions due to close proximity to 
the equator and Indian Ocean. Administratively, Dar es Salaam region has five 
municipalities namely Temeke, Kinondoni, Ilala, Ubungo and Kigamboni. Ubungo 
and Kigamboni districts were excluded from the study due to the fact that they have no 
regional referral hospitals. 
 
3.3  Study Population 
The study population were pregnant and lactating women living with HIV aged 15 
years and above attending PMTCT clinics at the three regional referral hospitals in 
Dar es Salaam; namely Mwananyamala, Amana and Temeke Hospitals. 
 
3.3.1  Inclusion Criteria  
All pregnant and lactating women living with HIV aged 15 years and above attending 
PMTCT services at one of the three regional referral hospitals in Dar es Salaam were 
included in the study. Willingness to participate in the study was also another criterion 
for inclusion in the study. 
 
3.3.2  Exclusion Criteria  
Pregnant and lactating women with complications including serious illness that 
required hospitalization were excluded from the study. Others were HIV positive 
mothers who were mentally challenged at the time of interview and those who were 
not fluent in Kiswahili.  
 
3.4  Sample size  
The proposed study included a sample of 294 HIV infected pregnant and lactating 







n = minimum sample size 
P = estimated prevalence of iron supplement use (85.5%), an estimated prenatal intake 
of iron supplements in Dar es Salaam (NBS, 2016) 
e = marginal error (0.05 for a 95% confidence level) 
191,  
 
To cater for stigma associated with HIV, error during data collection, refusal and non-
respondents 35% was added, making a sample size of 294 respondents.  
 
3.5  Sampling Procedure  
Three Regional Referral Hospitals in Dar es Salaam were purposively selected. These 
were Amana, Temeke and Mwananyamala. Stratification by physiological status was 
applied in order to identify pregnant and lactating mothers in each of the regional 
referral hospital. From each stratum 49 pregnant and lactating mothers were randomly 
chosen to represent the target population in the study area. Different sampling frames 
for pregnant and lactating women at each hospital at each day of interview were used, 
so that, each day will have a different sampling frame. All the pregnant and lactating 
women scheduled for a visit in a certain day constituted the sampling frame. Their 
names were routinely listed in the appointment register found at the PMTCT clinics.  
 
At the day of interview, the interviewer obtained two lists; one for pregnant and 





interviewed per day from each hospital; only four pregnant women and four lactating 
women were randomly chosen from their respective lists using their care and 
treatment center identification number (CTC-ID). Both unwilling respondents and 
those who did not come for their scheduled visit were replaced by the willing subjects. 
Interviews were carried out until the sample size for each hospital was reached. 
 
3.6  Recruitment and Training of Research Assistants  
Two research assistants were recruited to assist the researcher in data collection. One 
research assistant had a background in nutrition at a diploma level and the second one 
a Nurse Midwife. They both received two days training and pre-tested the data 
collection instruments before embarking in collecting data. The training was important 
to enable them to understand the study objectives, instruments of data collection, 
research techniques and ethical practices. After training, the study team was involved 
in pre-testing of the study tools in which a sample of 10 pregnant and 10 lactating 
women at Mnazi Mmoja Health Center were interviewed. Pre-testing allowed for 
refinement of the tools before actual fieldwork began. 
 
3.7  Data Collection Methods  
3.7.1  Interview Conducted to Study Subjects 
A structured questionnaire was developed in English then translated into Kiswahili for 
the purpose of data collection in this study. The questionnaire consisted of seven 
sections. The first part was about general information. The second part consisted 
socio-demographic and economic characteristics of the respondents. It comprised age, 





and general health. The third section comprised general health of the study subjects. 
The fourth sections sought information on knowledge of micronutrients especially IFA 
(section B).  
 
The fifths section, collected information on attitudes of mothers on the use of IFA 
supplements. Section six comprised information on, practices toward use of IFA 
supplements, section seven sought information on barriers to IFA supplements use 
among study subjects. The last part of the questionnaire solicited information on other 
health and lifestyle behaviours such as cigarette smoking and alcohol use among 
subjects. 
 
3.7.2  Focus Group Discussions and Key Informant Interviews 
In order to triangulate information collected by the questionnaire, focus group 
discussion (FGD) and key informants interview (KI) were used. The FGD team were 
conducted to gather information on the use and understanding of micronutrients 
especially iron and folic acid supplements in pregnant and lactating women living with 
HIV. Gender was not considered since the study subjects were women.  
 
The FGD sessions were conducted in each Hospital and the number of respondents 
were six to seven women in each group. Various issues related to IFA supplements use 
were discussed. This included their understanding about IFAS, important of IFAS in 
their life, availability of IFAS in their clinics and factors that influence and or 
discourage them from using IFAS. Several FGD sessions were conducted in one 
hospital until receiving no new information. Each session lasted 60 to 90 minutes. 





Key informant interviews were conducted in each Hospital gathering information on 
KAP on IFAS use among pregnant and lactating women living with HIV. The KII 
comprised Nurse Midwives and Medical Doctors conducting PMTCT clinics. The 
main theme for the interview was availability of IFAS, women KAP on IFAS and 
barriers towards using IFAS. Each session lasted 60 to 90 minutes.  
 
3.8  Data Analysis  
 Information was verified by looking for omissions and inappropriate entries on the 
same day. Problems were corrected immediately to ensure good data quality. Data 
collected using an interview guide for in-depth interviews were coded and analyzed 
using IBM SPSS. Descriptive statistics were performed, and statistical significance 
was determined at p-value <0.05. Means and frequencies were used to describe social 
demographic data and other related information about IFA supplements in pregnant 
and lactating women. Filled questionnaires were stored in a locked cabinet until 
completion of the study. Continuous variables such as subject’s age, gestational age 
and parity were summarized using means and standard deviations.  
 
Categorical variables such as level of education, marital status, occupation, monthly 
income and area of residence were reported using contingency tables as frequencies 
and percentages. Association between various independent variables such as socio-
economic status, knowledge, attitude and practices on iron and folic acid supplements 
use were examined using multivariate logistic regression. Variables with p value of 
0.05 were used in the multivariate models. Differences were considered significant at 





3.9  Ethical Considerations 
Various ethical procedures were observed during the process of conducting the current 
study. The study was approved by the Open University of Tanzania (OUT). The 
Researcher also sought approval from the three municipal authorities namely; DMO-
Temeke, DMO-Mwananyamala, DMO-Ilala Municipal, and the medical officers in 
charge in each of the hospitals. Before commencing data collection, the objectives of 
the study were explained to the participants and consent was sought from the subjects 
before enrollment in the study. Before collecting data, participants were given an 
opportunity to ask questions and interviews commenced after their questions had been 
answered. Interviews were conducted in privacy and confidentiality was observed at 
all times. Questionnaires were in the possession of the research team at all times 
during data collection and at the end of each day the questionnaires were stored in a 
locked cabinet accessible only to the research team. Data was entered into a password 


















4.1  Socio-Demographic and Economic Characteristics of the Study Population  
A total of 294 pregnant (50%) and lactating (50%) women were interviewed. The 
mean age of the study women was 28.7 ± 6.7 years ranging from 16-40 years (Table 
4.1). A quarter (25%) had not attained any formal education. With regards to 
household composition, 53.4% (n=157) of the households were headed by males. The 
mean household size was 4±2.1 (range 1-7) people. 
 
More than half 56.1% (n=165) of the households owned the houses they were living 
in. The remaining (43.9%) were renting. With regards to water supply 56.8% (n=167) 
of respondents had tap water supply while 43.2% (n=127) were using borehole water. 
Furthermore, the majority (94.2%) had electricity as the main source of light. About 
94% of the households owned television and 63.3% owned a radio.  
 
4.2  General Health of Study Subjects  
All of the respondents were HIV positive and receiving antiretroviral therapy (ART) 
(Fig 4.1). The findings revealed that, most of the respondents 97.6% were regularly 
receiving PMTCT care, and none of them was hospitalized due to any kind of 
problem. About 3.7% (n=11) of the respondents were taking medications other than 
ARVs such as Amoxylyin, Cotrimoxazole tablets and paracetamol tablets during the 
survey. Urinary Tract Infections (UTI) were found to be the persistent problem facing 





experienced among the study subjects. A good number of respondents were making 
scheduled visits to PMTCT clinics (97.6%) with very few (2.4%) having unscheduled 
visits.  
 
Table 4.1: Social Demographic and Economic Characteristics of the Study 
Population 
Parameter Answer Number Percentage 
Age(years) (Mean Age – 28.7±6.7) 
 
16-20     53 18.03 
 21-30       120 40.8 
 31-40 121 41.16 
Total  294 100 
Education level i No education 74 25.2 
 ii Primary 110 37.4 
 iii Secondary and above 110 37.4 
Total  294 100 
Marital status i Single 82 27.9 




Total  294 100 
Type of occupation i Civil servant 42 14.3 
 ii House Wife 69 23.5 
 iii Business 169 57.5 
 iv Casual labourer 14 4.7 
Total  294 100 
Monthly income (TZS)     i     <200,000 152 51.7 
     ii    ≥ 200,000 142 48.3 
Total  294 100 
Source of light  i Electricity 277 94.2 
 ii Kerosene 17 3.8 
Total   294 100 
Household assets i Television 285 96.9 
 ii Radio 186 63.3 
 iii Motorcycle 51 17.3 
 iv Bicycle 11 3.7 
Total  533 181 
Household houses i Owned house 165 56.1 
 ii Renting 129 43.9 
Total  294 100 
Sources of water i Tap water      167 56.8 
 ii  Borehole water                              127  43.2 
Total  294 100 






Figure 4.1: Year that the Study Subjects Were Diagnosed having HIV Infection 
 
4.3 Evaluation of the Level of Knowledge on Iron and Folic Acid 
Supplementations among HIV Infected Pregnant and Lactating Women  
Most of respondents (98%) did not know the foods that pregnant women should eat in 
comparison with non-pregnant women. Furthermore, the majority (74.4%) did not 
know the foods that lactating women should eat in comparison with non-lactating 
ones. Fortunately, 92.2% women had heard of word “micronutrient” however, 54.1% 
(n=135) were unable to mention any micronutrient they knew (Table 4.2). This limited 
understanding on micronutrients was also reported by subjects who participated in the 
FGD and Key Informant (KI) sessions respectively.  
“Micronutrients” is not a new word since we always use it and often 
hear from our health workers during nutritional education but, 
honestly we do not know exactly what micronutrients is”  
 
“To make mothers follow the session during health education and 
nutritional counseling, we go further referring to specific 
micronutrient supplements such as iron (red tablet) for increasing 
blood level and folic acid (yellow tablet) for prevention of birth defects 





Almost all respondents (99.6%) reported to have heard about anaemia. About 66% 
(n=194) knew the causes of anaemia with 28.9% (n=85) mentioning causes such as 
lack of iron in the diet. Twenty six percent (n=77) mentioned infection such as 
malaria, hookworm and HIV/AIDS to cause anaemia. About 10% (n=29) mentioned 
heavy bleeding as a cause of anaemia. Most of the respondents reported to be able to 
recognize someone with anaemia. Majority (95.9%) reported paleness of the body and 
47.9% (n=141) mentioned general body weakness as one of the manifestation of 
anaemia. Eighty six percent (n=253) of the respondents were aware of the way 
anaemia could be prevented. Some of the methods mentioned were taking diet rich in 
iron such as red-meat and spinach (25.2%). Other method was consuming Vitamin–C 
rich foods (such as oranges) during or right after meals (14.3%). Taking iron 
supplements as prescribed (26.1%) was also reported as a method of preventing 
anaemia. About 21% (n=62) of respondents mentioned managing anaemia by treating 
other infections such as malaria and Hookworms. 
Unfortunately, 12.5% were not aware on how to prevent anaemia. With regard to the 
benefits of iron supplements, 72.4% (n=213) stated that it helps in mental and physical 
development of the foetus while 27.5% (n=81) stated that it prevents maternal 
anaemia. Majority of the respondents (93.9%) reported to be aware of the benefits of 
using folic acid supplement during pregnancy. Some of the benefits mentioned 
included normal development of the nervous system of the foetus 94.5% (n=278) and 
prevention of birth defects 93.9% (n=276). About 6.1% of respondents failed to 
mention any benefit of folic acid supplements. The benefits of using IFA supplements 






“Being HIV positive, is already a problem to us, therefore 
prevention of anaemia, birth defects and HIV transmissions to our 
babies is our responsibility. So we are very careful in taking these 
supplements even though we are not getting enough supply”  
 
Table 4.2: Evaluation of the Level of Knowledge on Iron and Folic Acid 
Supplementations among HIV Infected Pregnant and Lactating Women 
Knowledge on IFA 
supplements use 
Response Number Percentage 
Ever heard about anaemia i. Yes 293 99.6 
 ii. No 1 0.4 
Total  294 100 
Causes of anaemia i. Lack of iron in the body 85 28.8 
 ii. Infection 77 26 
 iii. Heavy bleeding 29 10 
Total  294 100 
Recognising someone 
with anaemia 
i. Paleness of the body 282 95.9 
 ii. General body weakness 141 47.9 
Total  294 100 
Importance of iron 
supplements 
i. Help in mental and physical 
development off unborn 
baby 
213 72.4 
 ii. Prevents maternal anaemia 81 27.5 
Total  294 100 
Importance of folic acid 
supplements 
i. Normal development of 
nerves system of unborn 
baby and infants 
278 94.5 
 ii. Prevents birth defects 276 93.9 
 iii. Don’t know 18 6.1 
Total  572 194.5 
 
4.4 Attitude Toward use of Iron and Folic Acid Supplements among Respondents 
The findings indicated that slightly more than half (57.1%) of pregnant and lactating 
women attending PMTCT clinics did not perceive that their well being as well as their 
babies depend on the food they consume. Most of the respondents (89.8%) perceived 
that it is good for them to take any of micronutrients. Closer to two thirds (60.2%) 






About 76.9% (n=226) of the respondents did not perceive of any nutritional problem 
resulting from micronutrient deficiency (Figure 4.2). These poor attitudes on the use 
of IFA supplements were also reported by subjects who participated in the FGD and 
KI sessions:  
 “We all know the consequences of not taking IFA tablets during 
pregnancy and lactating, however, majority of us are unaware of even the 
taste of these supplements “These supplements have bad taste which 
discourages most of our clients from using them”  
 
“Most of our clients do not take these supplements simply because they 
do not feel sick and therefore they see no reasons of using them”. ”In 
some cases the clients have the supplements but do forget taking them as 
prescribed”  
 
Figure 4.2: Attitudes Towards use of Micronutrient Supplement among Pregnant 





4.5  Practices towards Use of Iron and Folic Acid Supplements  
The findings revealed that few (15%) of respondents were using IFA supplements 
throughout their pregnancy up to few weeks after delivery. About 54.8% (n=161) 
reported to use IFA supplements whenever they get free supply from their clinics and 
30% (n=89) were not using them at all about a quarter (25.8%) of respondents did not 
know even the taste of iron and folic acid (IFA) supplements despite their 
physiological status. Close to half (49.3%) of respondents were comfortable in using 
IFA supplements, while 24.8% (n=73) were not comfortable (Table 4.3). This finding 
is confirmed by subjects who participated in the FGD and KI sessions; 
“Although these tablets (IFA supplements) are very important to us, 
their limited supply discourages our routine use” 
 “These IFA supplements are like life saver to most of pregnant 
women especially the ones diagnosed to have low haemoglobin (Hb) 
level (before and after giving birth), however, most of women are not 
using them” 
 
Apart from IFA supplements, all respondents reported to be taking iron rich foods 
especially animal sources. About 18.4% were eating animal source such as red meat 
and fish once in a week. 38% (n=113) were eating twice and 43.2% thrice in a week. 
With regard to food rich in folic acid, food such as green leafy vegetables, beans, 
bread, cereals and citrus fruits, were reported to be consumed by the study women as 
they agreed to be able to afford the cost.  
 
Majority (81.6%) were able to consume food rich in folic acid twice every day while 
18.4% (n=54) were able to consume folic acid rich foods based on its availability. This 





 “We are always advised to use iron and folic acid tablets, so that 
we can avoid the possibility of low blood level and birth defects but 
the problem is that, we usually receive advice without supplements”  
 
“The mission for IFA provision is to prevent anaemia and birth 
defects to pregnant women. However, we are challenged with 
unreliable supply to our PMTCT clinics”  
 
Table 4.3: Use of Iron and Folic Acid Supplements among Respondents 
Practices towards IFAS                                            Number          Percentage 
Intake of IFAS i. Yes always 44 15.0 
 ii. Sometimes 161 54.8 
 iii. Not at all 89 30.3 
Total  294 100 
Consumption of animal 
source food 
i. Once a week 53 18.4 
 ii. Twice a week 113 38.4 
 iii. >three times a 
week 
127 43.2 
Total  294 100 
Consumption of folic acid 
rich foods (e.g greenleaf 
vegetables, beans, bread, 
cereals and citrus fruits) 
 
i. Twice a week 54 18.4 
 ii. > three times a 
week 
204 69.3 
 iii. Based on 
availability 
36 12.3 
Total  294 100 
Comfortability in using 
IFAS 
 
i. comfortable 145 49.3 
 
Comfortability in using 
IFAS 
 
ii. Not comfortable  73 24.8 
Comfortability in using 
IFAS 
 
iii. Don’t know 76 25.9 
Total  294 100 





4.6 Factors Associated with Iron and Folic Acid Supplements Use among 
Pregnant and Lactating Women Attending Prevention of Mother-to-Child-
Transmission Clinics using them” 
Results from Results from multivariate analysis showed the factors that significantly 
predisposed subjects to the use of IFA supplements among pregnant and lactating 
women living with HIV (Table 4.4). Subjects who reported to be comfortable in using 
IFA supplements were almost 3 times more likely to use IFA supplements than those 
who reported not being comfortable (OR= 2.86,95% CL:1.22, 6.66; p =0.01). It was 
also noted that, respondents who reported to have no difficulties in using IFA 
supplements were almost five times more likely to use them as compared to those who 
reported to have some difficulties (OR= 4.82, 95% CL: 2.42, 9.58; p<0.0001).  
 
Table 4.4: Factors Associated with IFA use among Pregnant and Lactating 
Women Attending PMTCT Clinics in Dar es Salaam 
Determinant OR (95% CI)  P value  
Education       
i. Secondary or higher 1    
ii. No formal education 0.82 (0.31, 2.13)  0.46 
iii. Primary education 1.25 (0.57, 2.72)  0.35 
Occupation       
i. Housewives  1    
ii. Civil servant 0.51 (0.12, 2.27)  0.71 
iii. Business 0.23 (0.04, 1.24)  0.01 
iv. Casual labourers 1.00 (0.27, 3.78)  0.07 
Comfort ability in taking IFA      
i. Not comfortable 1    
ii. Don’t know 1.29 (0.45, 3.71)  0.53 
iii. Comfortable  2.86 (1.22, 6.66)  0.01 
Difficulties taking IFA      
i. Difficulties  1    
ii. No difficulties 4.82 (2.42, 9.58)  <0.0001 
Encountered barriers in taking IFA      
i. No barriers 1    





Surprisingly, those who reported experiencing problems such as nausea and bad taste 
were 3 times more likely to use IFA supplements than those who did not report any 
problems (OR= 2.90, 95% CL:1.34, 6.29; p=0.01). Regarding occupation, business 
women were more likely to use IFA supplements (OR= 0.14, 95% CL 0.03, 0.83; 
p=0.01) compared to housewives, casual labourers and civil servants. Furthermore, 
education level was not associated with IFA use. 
 
4.7  Barriers Towards use of Iron and Folic Acid Supplements among Study 
Women 
Findings reveal that, 92% of study subjects did not get enough supply of IFA 
supplements on every PMTCT clinic visits they made. Therefore, some of them 58% 
were forced to buy IFA supplements from private pharmacies. However, a good 
number of the respondents (80%) were not able to afford buying the supplements. Few 
of the respondents (23.2%) were prescribed IFA supplements only in cases of low 
haemoglobin level. In occasions where IFA supplements were not available in the 
PMTCT clinics, subjects were instructed to buy from private pharmacies something 
which was beyond the financial capabilities of most of them. Apart from barriers such 
as unavailability and unaffordability of IFA supplements, some barriers such as 
nausea, bad taste and dark colour of stool were reported by subject. Among the group 
experiencing barriers, (43.5%) experienced nausea and (6.5%) bad taste. This was also 
supported by the FGD and KI interviews: 
“We are advised to use these tablets because of its benefit it has to 
our bodies; however, their taste discourages us from using them”.  
“Yes! These tablets are offered free of charge in our clinics, however 
in several cases they are not available hence we are forced to buy 





“Due to limited supply of these IFA supplements we advise our 
clients to buy them from private pharmacies” 
 
4.8 Other Health Behaviours and Lifestyles of the Pregnant and Lactating 
Women Living with HIV 
Apart from using IFA supplements and ARVs among subjects, these women were also 
engaged in other health and life style behaviours like any other human being. It was 
noted that, 4.4% (n=13) of study women were using alcohol, mostly taking one to two 
bottles of beer per day. In addition, 1.4% (n=4) were using one to two glasses of local 
beer in a day. However, majority (97%) were not taking any kind of alcohol. 
Fortunately, all respondents were not engaged in cigarette smoking. Furthermore it 
was also noted that 18% (n=53) among the respondents had a history of using 




















5.1  Introduction 
Anaemia among pregnant and lactating women causes a real health threat worldwide, 
especially in developing countries. The current study aimed at investigating KAP 
regarding use of IFA among women living with HIV attending PMTCT clinics in Dar 
es Salaam. The aim of the study was to determine Knowledge, Attitudes and Practice 
regarding use of IFA supplements among pregnant and lactating women living with 
HIV in Dar es Salaam.  
 
5.2  Knowledge on Iron and Folic Acid Supplement use among Study Subjects 
Knowledge regarding IFA supplements use among pregnant and lactating women 
living with HIV in this study is good. In the sense that, majority of respondents knew 
the benefits of IFAS use and the effects of not using the supplement to them and to 
their babies. This is an exception; a study by Ogundipe et al, (2012) shows 
disagreement with this statement as there is limited knowledge on IFA supplements in 
Northern Tanzania. This could be partly attributed to limited knowledge on the 
recommended dose of IFA supplements that should be started before conception until 
few months after giving birth.  
 
This finding was also in disagreement with work done in Kenya by Kimiywe et al, 
(2017) who revealed that, most women were not using IFA supplements due to their 
low knowledge on its importance. Despite of the World Health Organization 





few pregnant and lactating women visiting PMTCT clinics in Dar es Salaam reported 
using IFA supplements. This could be partly due to limited availability of these 
supplements in PMTCT clinics which was also noted during the current study.  
 
5.3  Attitudes towards Use of Iron and Folic Acid Supplements among 
Respondents 
Most of the respondents perceived that it is good for them to take IFA supplements as 
they understood its importance to their bodies. However, only a negligible proportion 
of women took IFA supplements throughout their pregnancy and lactation periods. 
This could be partly due to poor supply of IFA supplements in their PMTCT clinics. It 
was also noted that, study subjects who felt nausea after taking IFA supplements were 
the greater chance of using these supplements due to their benefits. These findings 
disagree various studies; (Kavishe et al, 2009) reported that, 22% of pregnant women 
who were taking IFA supplements and experienced side effects primarily nausea, were 
stopping completely taking IFA supplements.; Mgonja (2014) revealed that some 
women drop or ignore using the medication deliberately simply because they have bad 
smell or make them uncomfortable. In the current study, majority of study subjects 
believed that, they are likely to have IFA deficiencies because of inadequate supply of 
these supplements to them.  
 
5.4  Practices towards Use of Iron and Folic Acids Supplements 
In the current study, the number of women taking IFA supplements was low, despite 
its widely recognized benefits. This could be partly explained by lack of these 
supplements in PMCT clinics where they are supposed to be dispensed freely. In 





disadvantaged groups. These findings is in agreement with the study by Popa et al 
(2014) who reported that, in their study, less than half of the respondents were using 
IFA supplements during their pregnancy. However, this statement was in 
disagreement with the study by Mgonja, (2014) which revealed that IFA supplement 
were in abundant and the problem was the ignorance of study subject in using them.  
 
In the current study, it was also noted that there is frequent intake of foods rich in iron 
and folic acid by the study subjects. This could be due to improved understanding on 
the benefits of IFA rich foods during pregnancy as well as lactation.  Moreover, 
increased use of IFA rich foods might be brought about by shortage of IFA 
supplements in most of the health facilities. In the current study, it was noted that 
majority of the study subjects did not meet the WHO (2018) recommendations that 
pregnant women should start taking iron supplements (30mg a day) when they have 
their first prenatal appointment and folic acid (400 μg a day) as early as possible 
(ideally before conception) to prevent birth defects.  
 
5.5 Factors Discouraging Iron and Folic Acid Supplement Use 
While it is clear that pregnant and lactating women with HIV status will especially 
benefit from IFA supplementation. This study revealed that, most of pregnant and 
lactating women with positive HIV status were not using IFA supplements effectively. 
This could be due to poor supply of these supplements in their PMTCT clinics. The 
current study noted some minor side effects such as nausea and bad taste, when they 
use IFA supplements. However, the group experiencing these side effects on using 





than those not facing problems. This might be the outcome of counseling and health 
education given by health providers on importance of ARVs plus these supplements to 
their health and their future babies’. These findings agrees with the study in Kenya by 
Kimiywe et al, (2017) which revealed that few women reported to continue taking 
IFA supplements despite side effects. In addition, un-availability or limited financial 
support to purchase the supplements after receiving prescriptions from healthcare 
providers was one of the barriers to the use of antenatal IFA supplements in the 
women interviewed in the current study. Ogundipe et al, (2012) confirms the current 
study on low intake of IFA supplements due to their unavailability. This was also 
supported by Popa et al, (2014) who reported that, the proportion of women in their 
study group taking folic acid was still low, despite its widely recognized benefits, but 
could be explained by the lack of reimbursement for the cost of folic acid, which must 










CONCLUSION AND RECOMMENDATIONS 
 
6.1  Conclusion 
The use of IFA supplements for pregnant and lactating women living with HIV in Dar 
es salaam, Tanzania was low. Hence does not meet WHO recommendations for the 
prevention and treatment of anaemia during pregnancy, despite the high knowledge 
they have about the importance of these supplements. Socio-demographic factors 
including maternal age, level of education, marital status and HIV status were not 
significantly associated with use of supplements. Business women, women who felt 
comfortable in using IFA supplements and those who reported barriers were all 
significantly associated with use of supplements. Attitude towards use of IFA 
supplements among study subjects was good but few study subjects felt nausea and 
bad taste on using these supplements. On the other hand, practice on the use of IFA 
supplements among study subjects was not satisfactory. Only a small portion reported 
using the supplements throughout their pregnancy up to few weeks after delivery. 
 
6.2  Recommendations 
The study proposes the following;  
(i) The fact that IFA supplements intake was low in the study group the researcher 
recommends, more awareness campaigns on the use of IFA supplements while 
taking ARVs. This should be done to the general community and specifically to 





(ii) Following limited access to IFA supplements in PMTCT clinics, calls for 
Government of Tanzania through Ministry of Health Community Development, 
Gender, Elders and Children together with Tanzania Food and Nutrition Centre 
(TFNC) to implement its policy on IFA supplements availability to the clients at 
all the time they visit PMCT clinics. 
(iii) Following poor attitude toward use of IFA supplements to most of study subjects 
calls for health care personnel for provision of health and nutritional education 
on the importance so that clients could keep on taking them despite its 
limitations. 
(iv) With regard to the taste and smell of the supplements and nausea as a result of 
using IFAS, the study suggests the manufacturer to minimize these aspects so as 
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Appendix I: Questionnaire 
Questionnaire on Knowledge, Attitude and Practices on Iron-Folate Supplement 
use  among Pregnant and Lactating women living with HIV  in Dar es salaam 
 
General information 
CTC ID No _______ 
Date of interview ______/_____/________ (dd/mm/yyyy) 
Name of interviewer ______________________________ 
Hospital of recruitment (i)  Amana  (ii)  Mwananyamala (iii)  Temeke 
 
Physiological status (i)  Pregnant (ii )  Lactating 
If pregnant, gravidity _________If lactating, parity __________________________ 
 
Date of birth? _____/_____/____ (dd/mm/yyyy)   
  
Section one: Socio–demographic and economic characteristics of the study 
subjects 
1. What is your level of education?  
(i)  No formal education (ii)  Primary incomplete (iii)  Primary Complete 
(iv)  Secondary incomplete (v)  Secondary complete   (vi)  Above 





2. What is your marital status? (i) Single  (ii)  Married (iii) 
Divorced/separated (iv)  widowed 
3. Do you have a membership in any association for people living with HIV and 
AIDS?(i) Yes (ii)  No 
4. How many people live in your household? 
5. What is your relationship with the head of your household? (i)  Self (ii)  
Husband/partner (iii)  Son (iv)  Daughter (v)  Other (please specify) 
6. What is your occupation?(i)  Housewife (ii)  Civil servant (iii)  
Businesswoman (iv)  Casual labourer(v)  Other (please specify) 
7. What is the level of your monthly household income in Tanzanian Shillings? (i) 
 <100,000 (ii) 100,000-200,000 (iii)  200,000-500,000 (iv)  >500,000 
(v)  others (specify) 
8. How many family members depend on your household income for living? 
9. How much does your household spend on food per day in Tanzanian Shilling? 
10. Does your household own a house? (i)  Yes (ii)  No 
11. Does the house where you live have water supply? (i)  Yes(ii)  No 
12. Does the house where you live have electricity? (i)  Yes (ii)  No 
13. Does your household own a TV? (i)  Yes (ii)  No 
14.  Does your household own a car? (i)  Yes (ii)  No 
15. Does your household own a radio? (i)  Yes (ii)  No 
16. Does your household own a motorcycle? (i)  Yes (ii)  No 
17. Does your household own a bicycle? (i)  Yes (ii)   No 
Section B: General health of the study subjects 





19. Have you made unscheduled visit to a clinic in the past one month? (i)  Yes (ii) 
 No 
20. Have you been hospitalized in the past one month? (i)  Yes (ii)  No 
21. Are you currently taking any medications other than antiretroviral drugs? (i) 
Yes (ii)  No 
22. If yes. Which medication? 
23. Have you experienced any episodes of distress in the past one month? (i)  Yes 
(ii)  No 
24. If yes. Please explain to me what you experienced 
 
Section C: Knowledge about nutrition in general and micronutrient 
supplementations  
How should a pregnant woman eat in comparison with a non-pregnant woman to 
provide good nutrition to her baby and help him grow? Please mention four practices 
she should do.        a…………………………………  
      b………………………………………..   
     c………………………………..            
   d……………………………………… 
25. How should a lactating woman eat in comparison with a non-lactating woman to 
be healthy and produce more breast milk? Please mention four practices she 
should do:   
 a………………………………….  
 b……………………………………. 






26. Have you ever heard of micronutrients? (i)  Yes (ii)  No 
27. Do you know any micronutrient? (i)  Yes (ii)  No 
 
28. If yes. Mention any three of them      
i…………………………. 
ii……………………… 
  iii………………………………………… 
29. Most women would benefit from two types of supplements, or tablets, during 
pregnancy. Which are they?  (i) Iron supplements (ii)  Folic acid 
supplements (iii)  Don’t know or don’t remember (iv)  Other (specify) 
30. Can you tell me why it is so important to take folic acid supplements during 
pregnancy?(i)  For normal development of the nervous system of the unborn 
baby ( brain, spine and skull) (ii)  To prevent birth defects/abnormalities the 
nervous system of the unborn baby brain, spine and skull (iii)  Don’t know or 
don’t remember) (iv)  Other (specify) 
31. Have you heard about anaemia? (i)  Yes (ii)  No (iii)  don’t know or 
don’t remember 
32. Can you tell me how you can recognize someone who has anaemia? (i)  Less 
energy/weakness (ii)  Paleness/pallor (iii)  Spoon nails/bent nails 
(koilonychi) (iv)  More likely to become sick (less immunity to infections) (v) 
 Other (specify) 
33. What causes anaemia? (i)  Lack of iron in the diet/eat too little, not much (ii) 





HIV/AIDS) (iii)  Heavy bleeding during menstruation  (iv)  Don’t 
know   (v)  Other (specify) 
34. Can you tell me why it is so important to take iron supplements during 
pregnancy? (i)  For normal mental and physical development of the unborn 
baby (ii)  For prevention of iron-deficiency anaemia (iii)  Don’t know or 
don’t remember) (iv)  Other(specify) 
35. When a pregnant woman is undernourished, she is at risk of having a low- birth-
weight baby, meaning that the baby is small or has a low birth weight. What are 
the health risks for these babies? (i)  Slower growth and development (ii)  
Risks of infections/being sick (iii)  Risks of dying (iv)  Risks of being 
undernourished/having micronutrient deficiencies (v)  Risks of being sick 
once adult/developing chronic diseases in adulthood (heart disease, high blood 
pressure, obesity, diabetes) (vi)  Don’t know or don’t remember) (vii)  
Other (specify) 
36. How can anaemia be prevented? (i)  Eat/feed iron-rich foods/having a diet 
rich in iron (ii)  Eat/give vitamin-C-rich foods during or right after meals (iii) 
 Take/give iron supplements if  prescribed (iv)  Treat other causes of 
anaemia (diseases and infections) seek health care  assistance (v)  Continue 
breastfeeding (for infants 6–23 months old (vi)  Don’t know or don’t 









Section D: Attitudes toward use of iron and folic acid supplements among 
pregnant lactating women attending PMTCT clinics 
37. Do you think there are relationship between health and nutrition? (i)  Yes (ii) 
 No (iii)  Don’t know 
38. If yes. Which one/s 
39. How good do you think it is for you to take any of the micronutrients? (i)   
Good ( ii)  Not good ( iii)  Not sure 
40. How likely do you think you are to have any of the micronutrients? deficiency? (i) 
Not likely (ii)  Not sure or don’t know (iii)  Likely 
41. How serious do you think it is for you to have any of the micronutrients 
deficiency? (i)  Not serious (ii)  Not sure or don’t know  (iii)  Serious 
42. How do you feel after taking iron and folic acid supplement tablets (i)  
comfortable (ii)  Not comfortable (iii)  Don’t know 
 
Section E: Practices toward use of iron and folic acid supplements among 
pregnant and lactating women attending PMTCT clinics 
43.  What are the benefits of you taking micronutrients while pregnant or 
breastfeeding? Mention 
44. Are there any challenges you are experiencing in using micronutrient supplements 
(i)  Yes (ii)  No 
45. If yes, mention.       
 i…………………………………….. 
ii………………………………. 





46. How difficult is it for you to take any of the micronutrients supplements? (i)  
Not difficult (ii)  difficult 
47. Do you take iron and folic acid supplement tablets as instructed with health 
worker?(I)  Yes always (ii)  sometimes (iii)    Not at all 
48. Other than iron and folic acid supplement tablets do you consume animal foods? 
(i) Yes (ii)  No 
49. If yes, how often in a week? (i) Once (ii)  twice (iii)  three time (iv)  
every day  
50. Can you afford to to consume food rich in folic acid such as Greenleaf vegetable 
e.g. spinach, citrus fruits e.g. orange, beans, bread and cereals? (i)  Yes (ii)   
sometime  (iii) Not at all 
 
Section F: Barriers to iron and folic acid supplements use among study subjects 
51. Do you get supply of iron and folic acid tablets each visit of your clinic? (i)  
Yes (ii)  No 
52. Do you usually take iron and folic acid supplements? (i)  Yes (ii)  No 
53. Do iron and folic acid supplements available at you clinic every visit? (i)  Yes 
(ii)  No (iii)  Don’t Know/no answer 
54. If no, were else can you get such supplements (i)   Pharmacy (ii)   Hospital 
(iii)  Don’t know 
55. Can you afford to buy iron and folic acid supplements? (i)  Yes (iii)   No 
56. Are there any barriers encountered in using iron and folic acid supplements? (i) 





57. If yes which one (i)  Nausea (ii)   Bad taste (iii)  block stool (iv)  
others (specify) 
 
Section G: Other health behaviors and lifestyle 
58. Have you ever smoked cigarettes? (i)  Yes, currently smoking (go to 60) (ii)  
Yes, But quitted (iii)  No  
59. How many cigarettes do you smoke per day? 
60. Have you ever drunk alcohol? (i)  Yes, currently drinking (go to 63) (ii)  
Yes, but quitted (iii)  No 
61. What type of alcohol do you drink?  (i)  Local brews (ii)  Beers (iii)  
Wines (iii)  Whiskey (iv)  Others (please specify) 
62. How many drinks do you take per day? (Litres) 
63. Are you using any drugs not prescribed by your doctor for treatment of your 
illness?(i)  Yes (ii)  No  
64. What drugs are you using that are not prescribed by your doctor for treatment of 
your illness? 
Mention…………………………………………………………………………… 
65. Have you ever used medicines from traditional healers such as local herbs? 
66. (i)  Yes (ii)  No (finish the interview) 
67. Are you currently using medicines from traditional healers such as local herbs? (i) 
 Yes (ii)  No 
                           






Appendix II:  Interview Guideline for Key Information 
1. In your opinion, could you elaborate generally the availability of folic acid and 
iron supplement in PMTCT Clinic? 
 
2. Do you think pregnant women take folic acid and iron supplement as per 
instruction?   Please explain 
 
3. What kind of education do you provide to pregnant and lactating women 
attending to your PMTCT clinic concerning folic acid and iron supplementation? 
 
4. What are the barriers to folic acid and iron supplements use among HIV infected 
























Appendix III: Interview Guideline for Focus Group Discussions 
1. What do you know about iron and folic acid supplements? 
2. Do you think iron and folic acid supplements are important to your life? If yes 
can you explain how important is? 
3. Can you comment on availability of iron and folic acid supplements tablets in 
your clinic?     
4. What factors that influence and or discourage you from using iron and folic 
acid Supplements as advised in your clinics? 
Thank you 
 
 
 
 
 
 
 
 
 
 
 
 
 
